Loading...
Back to Apothecary
Home / Shop / ImmunoCell Multi-Purpose Defense
ImmunoCell Multi-Purpose Defense Lab Sourced Purity

Technical Specifications

Formulation Broad-Spectrum Clinical Prevention Matrix
Capsule Count 60 Vegetarian Capsules per bottle
Target Focus Chronic metabolic stability, anti-aging, and immune defense
Certifications Sustainably wildcrafted, 100% natural, GMP Certified facility
Prepared Formulas

ImmunoCell Multi-Purpose Defense

Complete Adaptogenic & Antioxidant Matrix — Prevents Diabetes & Cellular Mutations

4.88 / 5.0 (156 verified customer reviews)
Sourced Price ₹1,199
Worldwide Sourcing Dispatched in 24-48 Hours

Botanical Overview

ImmunoCell Multi-Purpose is an all-in-one daily longevity and wellness formula. Synthesized from standardized extracts of the top five clinical herbs—Moringa, Giloy, Ashwagandha, Neem, and Turmeric—it acts as a robust biological shield. This multi-purpose formulation regulates cellular aging, promotes glycemic stability, and builds powerful immune resilience to actively prevent the onset of chronic diseases.

Primary Wellness Benefits

  • Combats cellular aging by donating electrons to neutralize harmful free radicals.
  • Promotes steady, all-day glycemic levels and optimizes mitochondrial metabolism.
  • Builds active defense against cell mutagens and protects DNA strands from radiation.
  • Nourishes the nervous and endocrine systems, promoting energy without caffeine crashes.

Standardized Synergy Matrix

  • Moringa Leaf Extract (10:1)150mg
  • Giloy Stem Extract (10:1)150mg
  • Ashwagandha Root Extract (5% Withanolides)150mg
  • Neem Leaf Extract (10:1)100mg
  • Curcuminoid Standardized Extract (95%)100mg
  • Piperine Extract (95%)5mg

Recommended Sourced Usage

Take 1 capsule in the morning with breakfast and 1 capsule in the evening with dinner.

Purchase via WhatsApp Consultation
Evidence-Based Sourcing

Scientific Research & Publications

Clinical validation remains our foundational baseline. Review original published trials and molecular research papers associated with the core botanical ingredients in this blend.

Metabolic Sourcing
Sourced Botanical: Moringa

"Therapeutic potential of Moringa oleifera leaves in chronic metabolic disorders: A systematic review of clinical trials"

Authors: Gomez, J. V., & Tan, L. K. | Publication Source: Frontiers in Pharmacology (2019)
Key Sourced Takeaway:

Concluded that Moringa leaf powder significantly lowers blood glucose peaks by reducing carbohydrate absorption in the gut and facilitating glucose uptake in skeletal muscle tissues.

NCBI ID: PMID: 31258410 View PubMed Study
Adaptogenic Sourcing
Sourced Botanical: Ashwagandha

"An Investigation into the Stress-Relieving and Pharmacological Actions of an Ashwagandha Extract: A Double-Blind Study"

Authors: Lopresti, A. L., et al. | Publication Source: Medicine (Baltimore) (2019)
Key Sourced Takeaway:

Proven to reduce salivary cortisol levels by 30.5% and significantly lower anxiety scores, improving sleep quality and reducing systemic markers of chronic inflammation.

NCBI ID: PMID: 31517876 View PubMed Study
Adaptogenic Sourcing
Sourced Botanical: Giloy

"Immunomodulatory and anti-inflammatory properties of Tinospora cordifolia: A detailed review of active arabinogalactan polysaccharides"

Authors: Saha, S., & Ghosh, S. | Publication Source: International Immunopharmacology (2018)
Key Sourced Takeaway:

Identified that Giloy polysaccharides directly activate macrophages and increase the production of immunoglobulins, enhancing the body's natural defense against cellular mutations and viral pathgens.

NCBI ID: PMID: 29031129 View PubMed Study
Cellular Sourcing
Sourced Botanical: Turmeric

"Curcumin and Cancer: An Overview of the Molecular Pathways and Clinical Trials in Cellular Apoptosis"

Authors: Giordano, A., & Tommonaro, G. | Publication Source: International Journal of Molecular Sciences (2021)
Key Sourced Takeaway:

Revealed that Curcumin inhibits tumor growth and angiogensis while inducing programmed cell death (apoptosis) in drug-resistant breast, colon, and prostate cancer cell lines.

NCBI ID: PMID: 33925704 View PubMed Study